Maynard Um
-
-
-
-
-
-
-
ANI Pharma (ANIP) Tops Q1 EPS by 60c ; Offers Guidance
-
-
-
-
-
-
-
ANI Pharmaceuticals forms advisory council for ophthalmology business
-
-
-
-
-
-
-
CG Oncology wins court case, avoids 5% royalty to ANI Pharmaceuticals
-
-
-
-
-
-
-
Citi Upgrades 3SBio (1530:HK) (TRSBF) to Buy
-
-
-
-
-
-
-
Truist Securities Reiterates Hold Rating on ANI Pharmaceuticals (ANIP)
-
-
-
-
-
-
-
ANI Pharma (ANIP) Tops Q3 EPS by 26c ; Offers Guidance
-
-
-
-
-
-
-
ANI Pharma (ANIP) and Alimera Sciences (ALIM) Schedule Merger Closing for September 16th
-
448,576 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

